What is enGene Holdings Inc. Common Stock (ENGN) stock price today?

enGene Holdings Inc. Common Stock (ENGN) currently trades at $7.27 per share. The stock has a market capitalization of $535.25M and a P/E ratio of —x.

Is ENGN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, enGene Holdings Inc. Common Stock has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -1.27.

Is enGene Holdings Inc. Common Stock financially healthy?

enGene Holdings Inc. Common Stock's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -1.27 places it in the distress.

ENGN

enGene Holdings Inc. Common Stock

NASDAQ: ENGN · HEALTHCARE · BIOTECHNOLOGY

$7.27

+3.27% today

Updated 2026-04-30

Market cap

$535.25M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.25

Dividend yield

—

52W range

$3 – $12

Volume

0.4M

Market cap

$535.25M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.25

Dividend yield

—

52W range

$3 – $12

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-1.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$23.70

+226.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.19x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -1.27 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-29.06M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-24.46M	$-99.92M	$-55.14M	$-117.30M	$-29.75M
EPS	—	—	—	—	$-2.25
Free cash flow	$-17.75M	$-25.06M	$-49.21M	$-100.72M	$-29.06M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ENGN	$535.25M	31	4.3	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

enGene Holdings Inc. Common Stock trades at $7.27. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.27, it sits in the distress.

Frequently asked questions

What is enGene Holdings Inc. Common Stock's stock price?

enGene Holdings Inc. Common Stock (ENGN) trades at $7.27.

Is enGene Holdings Inc. Common Stock overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of enGene Holdings Inc. Common Stock (ENGN)?

The analyst target price is $23.70, representing +226.0% upside from the current price of $7.27.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-1.27 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-46.10%

Beta-0.05

50D MA$8.13

200D MA$7.28

Shares out0.07B

Float0.03B

Short ratio—

Avg volume0.4M

Performance

1 week-15.69%

1 month+16.50%

3 months-29.41%

YTD-20.27%

1 year—

3 years—

5 years—

Compare

ENGN vs LLY →ENGN vs JNJ →ENGN vs ABBV →Stock screener →